China’s Innovent Biologics signs US$10.5b Pfizer deal for 12 cancer drug trials
Julie Zhang
·
2026-05-29
·
via South China Morning Post
China’s Innovent Biologics has signed a global collaboration with pharmaceutical giant Pfizer worth up to US$…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。